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Abstract
Objective: aims of the current study were 1) to evaluate global cognitive function in patients with autonomic failure (AF) of
peripheral origin and 2) to investigate the effect of a documented fall in blood pressure (BP) fulfilling the criteria for
orthostatic hypotension (OH) on cognitive performances.
Methods: we assessed 12 consecutive patients (10 males, 6867 years old) with pure AF (PAF) or autoimmune autonomic
neuropathy (AAN) and 12 age- and gender-matched controls. All patients had no clinical signs of central nervous system
involvement and normal brain CT/MRI scan. Cognitive function was assessed on two consecutive days in 3 conditions: on
day 1, while sitting, by means of a comprehensive battery of neuropsychological tests; on day 2, while tilted (HUT) and
during supine rest (supine) in a randomized manner. BP and heart rate (HR) were continuously recorded non-invasively for
the whole duration of the examination.
Results: patients with PAF or AAN displayed a preserved global cognitive function while sitting. However, compared to
supine assessment, during HUT patients scored significantly worse during the Trail Making Test A and B, Barrage test,
Analogies test, Immediate Visual Memory, Span Forward and Span Backward test. Pathological scores, with regard to Italian
normative range values, were observed only during HUT in the Barrage test and in the Analogies test in 3 and 6 patients
respectively. On the contrary, in healthy controls, results to neuropsychological tests were not significantly different, during
HUT compared to supine rest.
Conclusions: these data demonstrate that patients with PAF and AAN present a normal sitting global cognitive evaluation.
However, their executive functions worsen significantly during the orthostatic challenge, possibly because of transient
frontal lobes hypoperfusion.
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Introduction
Orthostatic hypotension (OH) is defined as a systolic blood
pressure (SBP) fall of at least 20 mmHg or a diastolic blood
pressure (DBP) fall of at least 10 mmHg within 3 min of standing
or head-up tilt (HUT) to at least 60u [1].
Previous cross-sectional studies reported an association between
OH and cognitive decline in various conditions, including central
neurodegenerative disorders with autonomic failure (AF) [2–4].
However, prospective studies failed to demonstrate that OH was a
risk factor for cognitive decline, possibly because of the confound-
ing effects of age, concomitant disorders, medications, cerebro-
vascular or neurodegenerative processes [4–6].
Data on cognitive function in peripheral autonomic disorders,
rare conditions characterized by AF without central nervous
system (CNS) involvement, are scant. So far, a single retrospective
study reported cognitive impairment in 6 out of 14 patients with a
longstanding diagnosis of pure AF (PAF) [7]. However, blood
pressure (BP) values and cognition were not measured concur-
rently, patients were tested only while sitting, and 4 patients with
cognitive deficits had abnormal CT/MRI scan. A more recent
case series on 3 patients with autoimmune autonomic gang-
lionopathy reported that OH and elevated anti-body titer were
associated independently with neuropsychological impairment,
which improved, even in the seated normotensive position, after
plasmapheresis [8]. In a preliminary non-randomized study based
on 10 patients with central and peripheral causes of AF we
demonstrated that, despite a normal sitting global cognitive
evaluation, our patients presented a significant worsening of
global and executive cognitive functions during HUT [9].
However, except for few patients that had some pathological
performances in verbal abstract thinking and delayed recall of
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verbal memory, they scored within the Italian reference range
values.
Therefore, due to the paucity of data on cognitive function in
peripheral autonomic disorders and since previous studies did not
systematically take in consideration the effect of posture on
neuropsychological results, we performed the current study aiming
at: 1) evaluate global cognitive function in patients with AF of
peripheral origin by means of a comprehensive battery of
neuropsychological tests performed while sitting; 2) investigate
the effect of a documented fall in SBP fulfilling the criteria for OH
[1] on cognitive performances, carrying out neuropsychological
assessments in a randomized manner while the patients were
supine and during HUT.
Methods
Twelve consecutive patients with a confirmed diagnosis of AF of
peripheral origin and twelve age- and gender-matched controls
were enrolled in the study. Each participant gave written informed
consent before participating to the study, which was approved by
the institutional review board of the University of Bologna, Italy.
Patients’ inclusion criteria comprised the presence of neurogenic
OH [1], absence of clinical signs (parkinsonian, cerebellar or
pyramidal) of CNS involvement and normal brain CT/MRI scan
(absence of white matter lesions, cortical infarcts, atrophy and
hydrocephalus). Of the twelve patients enrolled in the study (10
males, 6867 years old, mean disease history 1265 years), 9 had a
probable PAF and 3 an autoimmune autonomic neuropathy
(AAN) (Table 1 and Table 2). Patients were classified as PAF on
the basis of symptoms associated with OH, of results of
cardiovascular reflexes and negative cerebrospinal fluid (CSF)
examinations [10,11]. Patients were classified as AAN if presented
AF of subacute onset with albuminocytologic dissociation in the
CSF [12]. All our AAN patients had negative ganglionic AChR
antibodies titers. All patients, except for patient 3, had features of
autonomic failure for many years, thus making it most unlikely
that this was the autonomic presentation of multiple system
atrophy or other central neurodegenerative disorder. All partic-
ipants were non-smokers and had no additional disorders that
might affect cognitive functioning.
Patients and controls underwent neuropsychological assessment
on 2 separate days in 3 different conditions: first, while seated, by
means of the Brief Mental Deterioration Battery (BMDB), Word
and Semantic Fluency and the Stroop Color Word Test, to
evaluate global cognitive function [11–13]; then, the day after, by
means of a selection of neuropsychological tests during supine rest
(supine) and head-up tilt (HUT) to assess the effect of OH on
attention and executive function. These tests were selected, on the
basis of our previous experience [9], in order to reduce the time
needed for this evaluation and made it feasible for our patients
during the HUT. This selection included the Digit Span Forward
and Backward for immediate and working memory, Barrage test
for visual search function, Immediate Visual Memory for visual
memory, Analogies test for verbal abstract thinking, Trail Making
A and Trail Making B for attention and executive functions [13–
16]. During HUT patients were kept to an angle ranging from 30u
to 50u, able to cause a fall of at least 20 mmHg in SBP but at the
same time, not to evoke symptoms. Controls were all kept to an
angle of 40u.
BP and heart rate (HR) were continuously recorded, non-
invasively by means of a Task Force Monitor (CNSystem, Austria)
for the whole duration of the examination.
On both days participants were assessed in the morning, in a
quiet clinical investigation room by the same examiner (R.P.).
Healthy controls were investigated at another time than the
patients and assessment of cognitive function was not blinded.
Participants were required to postpone their usual morning
medications until after the end of the evaluation and to abstain
from smoking and drinking alcohol or caffeinated beverages from
the night before the study.
Each of the HUT/supine session lasted approximately 15 min,
and was separated by 30 min of supine rest. The sequence of
execution of the HUT/supine evaluation was randomly assigned
in order to have half of the patients and controls who performed
neuropsychological assessment first during supine rest and then
during HUT and the remaining half who performed the tests in
Table 1. Patients’ characteristics and blood pressure and heart rate values while supine and during head-up tilt.
Pt Sex Age Diagnosis BMI Dis Hx Edu Supine HUT Delta (D)
SBP DBP HR SBP DBP HR SBP DBP HR
1 M 63 PAF 29.4 14 8 154 80 49 97 59 46 257 221 23
2 M 56 AAN 28.4 10 17 128 90 68 79 54 117 249 236 49
3 M 77 PAF 22.9 10 13 169 76 78 116 51 83 253 225 5
4 M 70 AAN 24.6 3 5 156 108 59 82 68 54 274 240 25
5 M 70 PAF 30.7 14 5 152 104 63 105 75 64 247 229 1
6 M 67 PAF 30.4 21 8 160 108 59 114 86 84 246 222 25
7 M 70 PAF 24.1 12 8 168 117 75 85 61 78 283 256 3
8 F 76 PAF 31.6 14 5 147 107 76 91 61 79 256 246 3
9 M 58 AAN 26.5 10 17 131 95 70 106 80 80 225 215 10
10 M 63 PAF 24.1 20 5 182 108 64 126 84 65 256 224 1
11 F 75 PAF 31.3 10 3 127 95 106 61 52 104 266 243 22
12 M 66 PAF 21 11 8 119 78 79 94 68 82 225 210 3
Age (years); AAN: Autoimmune autonomic neuropathy; BMI: body mass index; DBP diastolic blood pressure (mmHg); Delta (D): differences between HUT and supine
values; Dis Hx: disease history (years); Edu: years of education; F: female; HR: heart rate (b/m); HUT: mean value during the last minute of head-up tilt; M: male; PAF: pure
autonomic failure; Pt: patient; SBP systolic blood pressure (mmHg); Supine: mean value during the last 5 minutes of supine rest.
doi:10.1371/journal.pone.0085020.t001
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the reverse order. To reduce the effect of learning, parallel forms
of the tests were presented on each assessment and the sequence of
presentation of the various tests was randomized. Patients’
performances were compared on an individual basis to the Italian
reference range values [14,16]. The results to the neuropsycho-
logical tests during HUT and supine condition were compared by
using Wilcoxon signed-ranks test for related samples. Statistical
analysis was performed using IBM SPSS Statistics 20.0; a p,0.05
was considered significant.
Results
While sitting, the Mini Mental State Examination, the final
result of the BMDB (a measure of global cognition functioning),
the results to Word and Semantic Fluency test and to the Stroop
Color Word test were within the normal range in all patients
(Table 3).
Compared to supine assessment, during HUT patients scored
significantly worse in the Trail Making Test A (p = 0.021) and B
(p = 0.034), Barrage test final score (p = 0.013), Analogies test
(p = 0.003), Immediate Visual Memory (p = 0.019), Span Forward
(p = 0.008) and Span Backward test (p = 0.020) (Figure 1 and
Table 3).
Despite this significant worsening of executive functions,
reversible pathological scores, with regard to Italian reference
range values, were observed during HUT in the Barrage test and
in the Analogies test only in 3 and 6 patients respectively (Table 3).
On the contrary, controls’ results to neuropsychological tests
were not significantly different during HUT and supine assessment
(Figure 1).
To exclude a possible learning effect of test-retest, the results
obtained in the last assessment of the second day were compared
to the results obtained in the previous session, irrespectively of the
position in which they were performed (supine/HUT), and no
statistically significant differences were observed in any of the
performed test.
Discussion
These results demonstrate that patients with peripheral AF
present a significant reversible worsening of immediate and
working memory, sustained attention, visual search and abstract
thinking during the orthostatic challenge, but a normal global
cognitive function while seated. Pathological scores may be
observed in a minority of patients only during HUT. On the
contrary, no changes in cognitive function were observed in
healthy controls during HUT compared to supine assessment.
These data confirm our previous results and indicate that, even
after a prolonged disease history, OH ‘‘per se’’ does not seem to be
associated with permanent cognitive deficits. Our data suggest that
the previously reported association between OH and cognitive
decline may be the consequence of other factors, such as the
presence of white matter lesions, silent cerebral infarcts or central
neurodegeneration, possibly sharing the same pathogenesis of OH.
On the contrary, the BP fall observed during the orthostatic
challenge was associated with a reversible impairment of executive
function, which may be related to systemic hypotension with
transient cerebral hypoperfusion. This hypothesis is strengthened
by a previous brain SPECT study, in which orthostasis caused a
decreased blood flow in frontal areas in a patient with PAF, which
reversed to normal values while lying flat [17].
The absence of changes in neuropsychological results in healthy
controls during supine and HUT assessment indicate that our
results on PAF and AAF are solid and are not affected by the
motor performance related to the supine/HUT position or to a
possible learning effect.
We believe this data add valuable information to the current
knowledge of these rare disorders and may help to clarify previous
results regarding the relationship between OH and cognitive
function. Moreover, they are clinically relevant to understand that
patients with OH, if needed, have to be neuropsychologically
tested in supine position possibly with BP monitoring and
considering all the conditions that are known to worsen OH such
as food, alcohol and hypotensive drugs.
Table 2. Patients’ medications.
Patient Medications
1 Midodrine 2.5 mg BID; Acetylsalicylic acid 100 mg QD; Simvastatin 10 mg QD; Omeprazole 20 mg QD; Silodosin 8 mg QD; Calcitriol 0.25 QD;
Captopril 25 mg QD.
2 Midodrine 2.5 mg BID; Fludrocortisone 0.01 mg QD; Prednisolon 25 mg QD.
3 Prednisolon 50 mg QD; Midodrine 2.5 TID; Domperidon 10 mg TID; Lorazepam 1 mg QD.
4 Droxidopa 600 mg TID; Fludrocortisone 0.01 mg QD; Tyrosine 50 mg QD.
5 Midodrine 2.5 mg QD; Fludrocortisone 0.01 mg QD.
6 Droxidopa 600 mg BID; Captopril 50 mg QD; Atorvastatin 40 mg QD
7 Captopril 12.5 mg QD; Nimodipin 1 drop; Lansoprazol 30 mg QD; Acetylsalicylic acid 100 mg QD; Macrogol 13.8 mg QD.
8 Ticlopidine 250 mg BID; Midodrine 2.5 mg BID; Fludrocortisone 0.015 mg QD; Methylprednisolone 500 mg QD; Lorazepam 2.5 mg QD;
Rosuvastatin 5 mg QD.
9 Midodrine 2.5 mg QD; Fludrocortisone 0.01 mg QD; Nifedipine 15 drops.
10 Droxidopa 600 mg TID; Fludrocortisone 0.01 mg QD; Tyrosine 50 mg QD.
11 Lorazepam 1 mg QD; Etilephrine 7.5 mg TID; Alprazolam 0.25 mg QD.
12 Fludrocortisone 0.01 mg QD.
QD = once daily; BID = twice a day; TID = three times a day. Please note that patients were required to postpone their usual morning medications until after the end of
the evaluation.
doi:10.1371/journal.pone.0085020.t002
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Figure 1. Results of the neuropsychological tests during the head-up tilt (HUT) and supine sessions (Supine) in patients (PTs) and
controls (CNTRs). * = p,0.05.
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